Metabolic Control in Type 2 Diabetes Is Associated with Sulfonylurea Receptor-1 (SUR-1) but Not with KCNJ11 Polymorphisms

Archives of Medical Research

Volumn 40, Issue 5, 2009, Pages 387-392

  Nikolac, Nora ^a   Simundic, Ana Maria ^a   Katalinic, Darko ^a   Topic, Elizabeta ^a   Cipak, Andrea ^a   Zjacic Rotkvic, Vanja ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Genetic polymorphism; Glucose concentration; HbA1c; Sulfonylurea receptor 1; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA; SULFONYLUREA RECEPTOR 1;

AGED; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; WILD TYPE;

AGED; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; DIABETES MELLITUS, TYPE 2; EXONS; FEMALE; GENOTYPE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROSPECTIVE STUDIES; RECEPTORS, DRUG;

EID: 70349131959     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.06.006     Document Type: Article

References (23)

1. Mizuno C.S., Chittiboyina A.G., Kurtz T.W., et al. Type 2 diabetes and oral antihyperglycemic drugs. Curr Med Chem 15 (2008) 61-74
2. Reis A.F., and Velho G. Sulfonylurea receptor-1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus. Diabetes Metab 28 (2002) 14-19
3. Aguilar-Bryan L., and Bryan J. Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocrine Rev 20 (1999) 101-135
4. Florez J.C., Jablonski K.A., Kahn S.E., et al. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23 K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 56 (2007) 531-536
5. Hansen T., Echwald S.M., Hansen L., et al. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 47 (1998) 598-605
6. Inoue H., Ferrer J., Welling C.M., et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 45 (1996) 825-831
7. Laukkanen O., Pihlajamäki J., Lindström J., et al. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89 (2004) 6286-6290
8. Zhang H., Liu X., Kuang H., Yi R., and Xing H. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes. Diabetes Res Clin Pract 77 (2007) 58-61
9. Sesti G., Laratta E., Cardellini M., et al. The E23 K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 91 (2006) 2334-9233
10. Yi Y., Dongmei L., Phares D.A., et al. Association between KCNJ11 E23 K genotype and cardiovascular and glucose metabolism phenotypes in older men and women. Exp Physiol 93 (2008) 95-103
11. Reis F.A., Ye W.Z., Dubois-Laforgue D., et al. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 107 (2000) 138-144
12. Sacks D.B., Bruns D.E., Goldstein D.E., et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48 (2002) 436-472
13. Florez J.C., Burtt N., de Bakker P.I., et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 53 (2004) 1360-1368
14. Meirhaeghe A., Helbecque N., Cottel D., et al. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. Am J Med Genet 101 (2001) 4-8
15. Hart L.M., de Knijff P., Dekker J.M., et al. Variants in the sulphonylurea receptor gene: association of the exon 16-3 t variant with type II diabetes in Dutch Caucasians. Diabetologia 42 (1999) 617-620
16. Gloyn A.L., Hashim Y., Aschroft S.J.H., et al. Association studies of variants in promoter and coding regions of beta-cell ATP sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 18 (2001) 206-212
17. Zychma M.J., Gumprecht J., Strojek K., et al. Sulfonylurea receptor gene 16-3 polymorphism-association with sulfonylurea or insulin treatment in type 2 diabetic subjects. Med Sci Monit 8 (2002) CR512-CR515
18. Gloyn A.L., Weedon M.N., Owen K.R., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23 K variant is associated with type 2 diabetes. Diabetes 52 (2003) 568-572
19. Goksel D.L., Fischbach K., Duggirala R., et al. Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia. Hum Genet 103 (1998) 280-285
20. + channels. Diabetes 51 (2002) 875-879
21. Schwanstecher C., Neugebauer B., Schulz M., et al. The common single nucleotide polymorphism E23 K in K(IR)6.2 sensitizes pancreatic beta-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates. Diabetes 51 suppl 3 (2002) S363-S367
22. Barroso I., Luan J., Middelberg R.P.S., et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol 1 (2003) e20
23. Nielsen E.M., Hansen L., Carstensen B., et al. The E23 K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52 (2003) 573-577